Abstract Cerebrovascular and cardiovascular diseases are the leading causes of death and disability worldwide. They are complex disorders resulting from the interplay of genetic and environmental factors, and may share several susceptibility genes. Several recent studies have implicated variants of the Kalirin (KALRN) gene with susceptibility to cardiovascular and metabolic phenotypes, but no studies have yet been performed in stroke patients. KALRN is involved, among others, in the inhibition of inducible nitric oxide synthase, in the regulation of ischemic signal transduction, and in neuronal morphogenesis, plasticity, and stability. The goal of the present study was to determine whether SNPs in the KALRN region on 3q13, which includes the Ropporin gene (ROPN1), predispose to ischemic stroke (IS) in a cohort of Portuguese patients and controls. We genotyped 34 tagging SNPs in the KALRN and ROPN1 chromosomal region on 565 IS patients and 517 unrelated controls, and performed genotype imputation for 405 markers on chromosome 3. We tested the singlemarker association of these SNPs with IS. One SNP (rs4499545) in the ROPN1-KALRN intergenic region and two SNPs in KALRN (rs17286604 and rs11712619) showed signiWcant (P < 0.05) allelic and genotypic (unadjusted and adjusted for hypertension, diabetes, and ever smoking) association with IS risk. Thirty-two imputed SNPs also showed an association at P < 0.05, and actual genotyping of Electronic supplementary material The online version of this article
three of these polymorphisms (rs7620580, rs6438833, and
Introduction
Cerebrovascular diseases, such as stroke, and cardiovascular diseases, such as coronary artery disease (CAD) and myocardial infarction (MI), are among the top three leading causes of death and disability worldwide (Murray and Lopez 1997) . They are complex disorders resulting from the interplay of genetics and environment, and they share many risk factors, including age, sex, hypertension, dyslipidemia, diabetes, obesity, smoking, and physical inactivity. These atherothrombotic diseases most likely also share common pathogenic mechanisms such as inXammation and appear to have common susceptibility loci. For instance, a locus on 9p21 has been Wrmly associated with vascular pathologies such as heart disease, stroke, aneurysms, and atherosclerosis (Matarin et al. 2008; Larson et al. 2007; McPherson et al. 2007; Helgadottir et al. 2007 Helgadottir et al. , 2008 ; Karvanen et al. 2009; O'Donnell et al. 2007; Ye et al. 2008) .
The GENECARD study for early-onset CAD (Hauser et al. 2004) , the Diabetes Heart Study (DHS) for cardiovascular disease (CVD), type 2 diabetes (T2D) and metabolic syndrome (MS) (Bowden et al. 2006) , and a meta-analysis of four linkage studies for coronary heart disease (Chiodini and Lewis 2003) identiWed linkage peaks on chromosome 3q. Ordered subset analysis signiWcantly increased the evidence for linkage at 3q13 (LOD = 5.10, P = 0.008) in GENECARD families with lower-risk lipid proWles and fewer risk factors (Shah et al. 2006) , and subsequent peakwide association mapping led to the identiWcation of twelve SNPs in the Ropporin (ROPN1, OMIM 611757) and KALRN (OMIM 604605) genes associated with early-onset CAD ). Validation in additional datasets revealed that SNP rs9289231 in the Wrst intron of a KALRN alternative transcript was associated with early-onset CAD in all white data sets examined, and the risk allele of this SNP was associated with atherosclerosis burden in human aortas ). Additionally, follow-up of the DHS 3q linkage peak revealed that the KALRN polymorphism rs4234218 is associated with T2D, MS, and combined phenotype (T2D + MS + CVD + coronary calciWed plaque) (Rudock et al. 2008) .
Furthermore, a recent and well-powered genomewide association study (GWAS) conducted on four European and American cohorts including 1,164 ischemic stroke patients and 18,058 controls (Ikram et al. 2009 ) showed that several polymorphisms in Kalirin are associated with IS (0.001 < P < 0.01), even though below the genomewide signiWcance level.
Kalirin is an extremely large gene with 60 exons spanning over 620 kb, characterized by multiple promoters producing developmentally regulated isoforms predominantly expressed in the brain (McPherson et al. 2004) . KALRN encodes for a guanine nucleotide exchange factor (GEF) that activates Rho proteins, and is therefore a multifunctional protein involved, among others, in neuronal morphogenesis and secretory granule maturation (Ferraro et al. 2007; Rabiner et al. 2005) . Additionally, Kalirin may have a neuroprotective role by inhibiting inducible nitric-oxide synthase (iNOS) activity (Ratovitski et al. 1999) , and participates in the regulation of ischemic signal transduction (Beresewicz et al. 2008) .
The goal of the present study was to conWrm if SNPs in the ROPN1-KALRN region predispose to ischemic stroke (IS).
Patients and methods

Study subjects
Five-hundred sixty-Wve unrelated patients with a clinical diagnosis of IS, who were under the age of 65 at stroke onset, were recruited through Neurology and Internal Medicine Departments throughout Portugal. Stroke was deWned by the presence of a new focal neurological deWcit, with an acute onset and with symptoms and signs persisting for more than 24 h. The stroke was conWrmed in all patients by a computed tomography scan in 97% of cases and/or magnetic resonance imaging in 25% of patients. All patients were seen, and all neuroradiology tests were reviewed by study neurologists. Trauma, tumors, infection, and other causes of neurological deWcit were excluded.
Data collection forms were developed for this study that included extensive clinical information such as stroke characteristics, general clinical observation, neurological symptoms and signs, complications and interventions during hospitalization, and situation at discharge. Data were also collected on relevant lifestyle aspects and previous clinical risk factors.
Five-hundred seventeen unrelated healthy individuals were included in this study as a control sample population. Since stroke is a late-onset disease, the control group was selected from a group of healthy volunteers with a higher mean age than the case group, thus minimizing the chances for mis-classiWcation as "stroke-free". Control individuals were veriWed to be free of stroke by direct interview before recruitment, but no brain imaging studies were performed. The interview also included questions on established clinical and lifestyle risk factors for stroke. All participants were adults of Portuguese Caucasian origin.
The research protocol was approved by the Ethics Committees of participating institutions, and all participants provided informed consent.
SNP selection and genotyping
All SNPs originally found associated with CAD in the CATHGEN initial dataset ) were genotyped Wrst and then additional haplotype tagging SNPs were included in the study. Genotypes of 30 European (CEU) family trios were downloaded from the HapMap Release 21/phaseII Jul06, on NCBI B35 assembly, and haplotype tagging SNPs in the ROPN1-KALRN region were identiWed in Haploview 4.0 (Barrett et al. 2005 ) with the following options: pairwise mode, r 2 > 0.8, and minor allele frequency (MAF) >0.1. A total of 34 SNPs were genotyped in a 384-well format, 31 of which using Sequenom's (San Diego, USA) iPlex assay (primer extension of multiplex products with detection by matrix-assisted laser desorption/ionization time-of-Xight mass spectrometry) following manufacturer's protocol and detected in a Sequenom MassArray K2 platform. The primer sequences are available upon request and were designed using Sequenom's MassARRAY ® Assay Design 3.0. Extensive quality control was performed using eight HapMap controls of diverse ethnic aYliation, sample duplication within and across plates, non-Mendelian inheritance check in three large pedigrees, Hardy-Weinberg equilibrium (HWE) in the control group (P > 0.05), and a minimum of 90% call rate. Genotype determinations were performed blinded to aVection status. The SNPs which failed at least one quality control (rs12634530, rs12637456, and rs13075202) or that could not be genotyped (rs1444754) using the iPlex assay were genotyped using the TaqMan allelic discrimination assays (assays-on-demand C__11236577_10, C__11236574_10, C___1720000_10, and C___9532531_10, respectively) from Applied Biosystems (Foster City, USA). Even though SNP rs13075202 was out of HWE in the control dataset (P < 0.05), it was considered for further analysis as it was genotyped consistently in two assays (iPlex and assay-ondemand) and passed all other quality checks. All the genotyping was performed in the Genomics Unit of the Instituto Gulbenkian de Ciência.
Statistical analysis
An unpaired Student's t test and a 2 test were used to compare quantitative and qualitative clinical and demographic data, respectively, between cases and controls.
2 tests for HWE, allelic association of SNPs with IS risk, and linkage disequilibrium (LD) plots were performed using Haploview 4.0 (Barrett et al. 2005) . The genotypic association between IS and each SNP was examined by logistic regression analyses using the SNPassoc v.1.4-9 package (González et al. 2007 ) implemented in the R freeware (http://cran.r-project.org/). To adjust the association analyses for relevant confounding factors, hypertension, diabetes, and ever smoking were included as covariates in multivariate logistic regression with backward elimination of risk factors. The interaction i among these covariates in regression models was not strong (¡0.5 < i < 0.5). Odds ratios (ORs) and their associated 95% conWdence intervals (CIs) were uncorrected for confounding variables in the 2 tests and unadjusted logistic regression, and corrected for covariates in adjusted regression models. Results were considered signiWcant below the conventional level of 0.05. Since there is LD among some of the genotyped SNPs, we did not perform corrections for multiple testing, and uncorrected P values are reported.
Imputation
Ungenotyped SNPs in chromosome 3 were imputed with PLINK v1.04 (Purcell et al. 2007 ) using HapMap data (Release 22, 154783 SNPs in chromosome 3 with MAF greater than 0.01 and genotyping rate greater than 0.95 in the 60 CEU founders). For every imputed SNP, PLINK provides an information content metric INFO, ranging from 0 to 1 (although it can be greater than 1 occasionally). A higher INFO value generally means a better SNP imputation. All imputed SNPs with MAF in controls smaller than 0.05 and with INFO < 0.5 were excluded. For SNPs that have been genotyped, PLINK calculates the concordance rate among observed and imputed genotypes.
To conWrm the imputation results, three imputed SNPs (rs7620580, rs6438833, and rs11712039) signiWcantly associated with IS were fully genotyped in our casecontrol biobank, and tested for association as described previously. Table 1 summarizes the principal characteristics of the dataset used in this study. The average age at the Wrst stroke is 51.7 § 9.5 years. Since stroke is a late-onset disease, we chose to have the control group signiWcantly older than the case group to minimize misclassiWcation biases. As expected, male:female ratio, hypertension, diabetes, ever smoking, and ever drinking were signiWcantly higher in IS patients than in controls.
Results
We Wrst tested the association with IS of the 12 SNPs (Table 2) , originally found associated with CAD in the CATHGEN initial dataset (SNPs 2, 3, 4, 7, 8, 9, 12, 14, 20, 22, 31, and 37 in Wang et al. 2007 ), which includes the rs4234218 (SNP 31 in Wang et al. 2007 ) associated with cardiovascular risk, T2D, and MS (Rudock et al. 2008) . These polymorphisms are located in ROPN1, ROPN1-KALRN intergenic region and in the 5Ј region of the KALRN gene. In our dataset, all of these polymorphisms are also haplotype tagging SNPs, with the exception of rs7613868 and rs12637456 (SNPs 7 and 9, respectively, in Wang et al. 2007 ) which are in almost complete LD (r 2 = 0.97; Fig. 1 ). We found that a cluster of SNPs in low LD (pairwise r 2 · 0.56) in the ROPN1-KALRN intergenic region (rs4499545, rs7613868/rs12637456, and rs12634530) was associated with IS in allelic and unadjusted genotypic tests ( Fig. 1; Supplementary Table 1 ). The association of SNP rs4499545 remained signiWcant after adjustment for covariates (P = 0.028, OR [95% CI] = 1.31 [1.03-1.67]). rs9289231, which has been associated with early-onset CAD and atherosclerosis burden in human aortas ) and rs4234218 were not associated with IS in any test performed (Fig. 1) . Given the evidence for association of genetic variants in the ROPN1-KALRN region with IS, although with a diVerent variant than previously reported to be associated with cardiovascular risk, we decided to further investigate this region by analyzing additional SNPs. We genotyped 22 additional haplotype tagging SNPs in the ROPN1 region, the ROPN1-KALRN intergenic region, and in the 5Ј region of KALRN (Table 2) . Since the KALRN gene is extremely large, we chose to concentrate our eVorts on the KALRN region with the reported associations.
Two newly analyzed SNPs in the ROPN1-KALRN intergenic region LD block (rs2280422 and rs2332719) and two SNPs in KALRN (rs17377867 and rs6784664) were associated (0.003 < P < 0.042) in allelic and unadjusted log-additive model tests, but these associations became marginal (0.05 < P < 0.15) when adjusted for covariates ( Fig. 1 ; Supplementary Table 1 ). Inclusion of any combination of two of these covariates had the same overall eVect, but it is not always the same polymorphisms that become marginally signiWcant, suggesting that this may be mostly a power issue and not a biologically relevant phenomenon. On the other hand, two new SNPs in KALRN (rs17286604 and rs11712619) demonstrated association in all tests performed ( Fig. 1; Supplementary Table 1) . Table 3 presents more detailed association results for the three genotyped SNPs demonstrating an association with IS in all tests performed (rs4499545, rs17286604, and rs11712619). Similar to the rs4234218 association with cardiovascular risk, T2D, and MS (Rudock et al. 2008) , the most signiWcant results for these three SNPs were under the dominant genetic model (Table 3) . These polymorphisms are in very low LD (all pairwise r 2 < 0.34 and DЈ < 0.58). SNP rs4499545 remains signiWcantly associated when the other two markers are used as covariates, while the association subsides for rs11712619 when adjusted for rs17286604. These data suggest at least two independent lines of evidence for association of KALRN with IS.
Even though we investigated 23 haplotype tagging SNPs in the 5Ј end of KALRN, a large portion of its natural genetic variation was not assessed because it is a very large gene with a high degree of genetic diversity. We therefore performed genotype imputation for SNPs in chromosome 3 using data from HapMap as well as the genotypes observed at the 34 fully genotyped polymorphisms. We obtained imputed genotypes meeting minimum quality standards (MAF in controls¸0.05 and SNP INFO¸0.5) for 405 SNPs in and around ROPN1 and KALRN (Fig. 2) . As expected, the imputed SNPs with higher information content metric (SNP INFO > 0.8) are located in the region of genotyped SNPs. As an additional quality control, the genotyped SNPs are dropped one at a time and imputed using the other observed genotypes. A concordance rate between observed and imputed genotypes can be calculated for these markers, and 90% of the genotyped SNPs had a concordance rate >85% between imputed and observed genotypes (Fig. 2) . Thirty-two of the imputed polymorphisms have an allelic association with IS risk at a more stringent P threshold Table 2) . Among the top Wve SNPs (P · 0.001), the Wrst one (rs6790975) has a modest SNP INFO metric (0.598), and therefore its association has to be taken with caution, but the remaining four markers (rs4678111, rs7620580, rs9820396, and rs1444770) have a very high SNP INFO metric (0.93) and are in complete LD (Fig. 2) . The LD among the top 32 imputed associated SNPs (Fig. 2 ) also suggests the existence of several independent clusters of association with IS in the 5Ј region of the KALRN gene, such as the rs6438833-rs1373612, rs6779809-rs11712039-rs11719349 and rs4678111-rs7620580-rs9820396-rs1444770 clusters.
To validate the imputation results, we additionally genotyped in our dataset three SNPs (rs6438833, rs11712039, and rs4678111) representing the abovementioned clusters of association (highlighted in light gray in Table 2 ), and tested their association with IS. The average concordance rate among observed and imputed genotypes was 92%. All three polymorphisms were associated with IS (Table 3;  Supplementary Table 1 ).
Among the SNPs tested and associated with IS in this study, SNP rs11712039 has also been associated with IS (0.001 < P < 0.01) in the Ikram et al. (2009) IS GWAS, as shown in Supplementary Table 1. rs17286604 and rs11712619, which are associated with IS in our Portuguese sample, were modestly associated in the GWAS, and SNP rs4499545 has not been tested (Supplementary Table 1 ).
Discussion
In this study, we highlight for the Wrst time an association of the Kalirin gene with risk for ischemic stroke. Given that KALRN has already been implicated in susceptibility to cardiovascular disorders and some of its risk factors (e.g. T2D) Rudock et al. 2008; Ikram et al. 2009 ), we propose that Kalirin may constitute a novel genetic risk factor for vascular phenotypes.
Kalirin is an extremely complex gene generating many alternative transcripts under the control of several promoters in a tissue-speciWc and developmentally regulated manner (McPherson et al. 2004; Johnson et al. 2000; Ma et al. 2001 ) encoding multidomain and multifunctional proteins (McPherson et al. 2002) . A number of recent studies have demonstrated that Kalirin-7, the most abundant isoform in adult brain , is involved in dendritic spine development, plasticity, and stability (Penzes and Jones 2008) . Kalirin-7 gene transcripts are underexpressed in Alzheimer's disease (AD) hippocampal specimens (Youn et al. 2007a) , and underexpression of Kalirin-7 increases iNOS (inducible nitric oxide (NO) synthase) activity in cultured cells and correlates with increased iNOS activity in AD hippocampus (Youn et al. 2007b ). Interestingly, Kalirin is known to associate with iNOS in vitro and in vivo and to prevent iNOS dimerization, and therefore iNOS activity (Ratovitski et al. 1999) . NO, a potent cell-signaling, eVector, and vasodilator molecule characterized by its strong reactivity and diVusibility, is produced in a complex and tightly controlled process by three NO synthases: iNOS, neuronal synthase (nNOS), and endothelial synthase (eNOS). Cytokines, endotoxin, or other proinXammatory stimuli induce iNOS expression in Fig. 1 Association results and pairwise linkage disequilibrium (LD) among all genotyped polymorphisms. Allelic (black squares) as well as crude (green disks) and adjusted (red triangles) genotypic (log-additive model) association results are shown. Odds ratios (ORs) and 95% conWdence intervals (CIs) are depicted with stars and bars for signiWcantly associated (P < 0.05) polymorphisms. In the LD plot, the white-black gradient shading within each diamond represents the magnitude of LD using the pairwise LD statistic r 2 (from lower to higher values, respectively). The positions of the SNPs relative to the ROPN1 and KALRN genes are indicated. Boxes surrounding SNP names indicate the 12 polymorphisms that we Wrst genotyped virtually all tissues, while nNOS and eNOS are constitutively expressed primarily in neural tissue and endothelium, respectively, which are the principal tissues involved in stroke. Several published case-control studies describe an association of genetic variants in eNOs with ischemic stroke risk (Domingues-Montanari et al. 2008 ), and we have found an association of nNOS with IS (personal communication). Kalirin-7 is involved in the regulation of ischemic signal transduction (Beresewicz et al. 2008) , and may play a neuroprotective role during inXammation of the central nervous system by inhibiting iNOS activity (Ratovitski et al. 1999) . It would therefore be interesting to assess the role played by genetic variation in Kalirin in stroke severity and recovery, as well as epistatic eVects between KALRN and NO synthases in ischemic stroke risk. Several independent Kalirin polymorphisms have now been associated in previous studies Rudock et al. 2008; Ikram et al. 2009 ) and in the present report with vascular phenotypes, and therefore it is not clear which is(are) the exact susceptibility variant(s). Kalirin appears to be a pleiotropic protein, and it is possible that diVerent variants in the same gene cause related phenotypes. Alternatively, the causal polymorphism might not have been directly studied yet, as suggested by our imputation approach. Given that we had genotyped a relatively high number of haplotype tagging SNPs in the KALRN gene region, we were able to impute hundreds of neighboring polymorphisms with high conWdence and identiWed many SNPs with stronger association than those directly genotyped. Genomewide imputation is currently performed routinely in whole-genome association studies to increase power, but "local" imputation may also be a powerful approach to detect novel associations when there is a dense map of observed genotypes. We validated this local imputation approach in our dataset through direct genotyping.
Another possibility is that Kalirin demonstrates an even stronger association with a pathogenic mechanism (e.g. inXammation) or subtype (e.g. small vessel) of vascular disease that has not yet been tested directly or corrected for in the statistical analyses. This hypothesis is supported by the signiWcant increase in the evidence for linkage at 3q13 (LOD = 5.10, P = 0.008) in GENECARD families with lower-risk lipid proWles and fewer known risk factors (Shah et al. 2006 ). We did not test the association of Kalirin with IS subtypes since a much larger sample size would be required to have a representative number of individuals in each subtype and genotype category.
Population stratiWcation was a frequent confounding factor in previous association studies. It can be corrected for when genomewide data is available, but is harder to address in candidate gene studies when no ancestry-informative markers are known. Population genetic studies with very large numbers of autosomal markers have never been conducted in self-described Portuguese Caucasians. Additionally, there are no major historical events that lead us to suspect that a signiWcant proportion of Portuguese Caucasian individuals are of mixed backgrounds. Therefore, we do not expect that an underlying population substructure in our sample accounts for the observed associations.
The type of correction for multiple testing that must be employed is subject to controversy, but our positive association Wndings would not survive the most conservative Bonferroni correction. However, replication in multiple independent datasets remains the gold-standard of association studies, even for modest associations. Our study highlights the importance of replicating associations that fall below the genomewide signiWcance threshold. These variants may account for part of the missing heritability.
We believe that the Kalirin association is promising because of the multiple independent lines of evidence for )   rs6790975  rs1920616  rs6794106  rs1920625  rs9811597  rs6438833  rs1373612  rs11720960  rs6779809  rs11712039  rs11719349  rs11719623  rs4289301  rs9847323  rs920894  rs4420813  rs4678105  rs11706831  rs4678111  rs2289778  rs7620580  rs9820396  rs1444770  rs6438838  rs2276740  rs4371456  rs1838473  rs6438839  rs1025957  rs17289013  rs11717452  rs16835717 -log P association, namely the association of several uncorrelated SNPs, the replication of the most associated SNP results on the Ikram et al. (2009) , GWAS published study, and the previous reports of association with cardiometabolic syndrome Rudock et al. 2008) . Additional replication studies in other independent datasets with stroke and vascular pathologies are needed to further conWrm Kalirin's role in vascular disease susceptibility. Deep sequencing may have to be used to precisely identify the causal genetic variant.
